Related Experiment Video
Updated: Jun 21, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
The systemic immune-inflammation index is an independent predictive factor in predicting major amputation in chronic
Ahmet Can Çakmak1, Mehmet Bülent Vatan2, Betul Sarıbıyık Çakmak2
1Department of Cardiology, Sakarya University Education and Research Hospital, Sakarya, Turkey.
Insights
High systemic immune-inflammation index (SII) predicts major amputation risk in patients with lower extremity peripheral arterial disease (LEAD). This straightforward marker aids in guiding treatment decisions for limb salvage.
Area of Science:
- Vascular Surgery
- Inflammatory Biomarkers
- Amputation Prevention
Background:
- Lower extremity peripheral arterial disease (LEAD) encompasses arterial narrowing and occlusion, with chronic limb-threatening ischemia (CLTI) representing its most severe form.
- CLTI significantly increases the risk of major amputation.
- The systemic immune-inflammation index (SII), derived from neutrophil, lymphocyte, and platelet counts, reflects a patient's inflammatory and immunothrombotic state.
Purpose of the Study:
- To investigate the association between an elevated systemic immune-inflammation index (SII) and the likelihood of major limb amputation in patients with LEAD.
- To evaluate SII as a predictive biomarker for major amputation in this patient population.
Main Methods:
- A cohort of 140 patients with Rutherford 5 or 6 LEAD and foot wounds undergoing endovascular intervention was analyzed.
- Demographic and laboratory data, including neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and SII, were collected.
- Receiver operating characteristic (ROC) curve analysis and logistic regression were employed to assess SII's predictive value for major amputation.
Main Results:
- Major amputation was required in 19.2% (27/140) of the patients.
- Patients undergoing major amputation exhibited significantly higher neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and SII values.
- ROC analysis identified an SII cut-off of 1018 as optimal for predicting major amputation (AUC: 0.84, sensitivity: 81%, specificity: 73%).
- Logistic regression confirmed high SII as an independent predictor of major amputation (OR = 1.001, p = .009).
Conclusions:
- Elevated SII is significantly associated with an increased risk of major amputation in patients suffering from LEAD with foot wounds.
- SII serves as a valuable and easily accessible biomarker for predicting major amputation risk.
- The findings suggest SII can aid clinicians in making informed treatment decisions for limb preservation in LEAD patients.
Abstract:
BackgroundLower extremity peripheral arterial disease (LEAD) is characterized by the narrowing and occlusion of arteries in the lower extremities. The most severe form of LEAD is chronic limb-threatening ischemia (CLTI), which carries a poorer prognosis for major amputation. The systemic immune-inflammation index (SII) is an index developed to simultaneously reflect the inflammatory and immunothrombosis status of patients, based on platelet counts and the neutrophil-to-lymphocyte ratio.ObjectiveOur study aimed to investigate the relationship between elevated SII and major limb amputation.MethodThe study included 140 patients with foot wounds (Rutherford 5 or 6) due to LEAD who were scheduled for endovascular intervention between 2018 and 2023. Major amputation was required in 27 patients (19.2%). The neutrophil-to-lymphocyte ratio (2.1/2.8/3.8 vs 3.8/6.6/9.3, p < .001), platelet-to-lymphocyte ratio (103.8/128.8/162.9 vs 132.8/212.3/314.6, p < .001), and SII (527/720/1055.5 vs 1108/1951/3807, p < .001) were higher in the major amputation group. ROC curve analysis determined that the optimal cut-off value for SII to predict major amputation in LEAD patients was 1018, with a sensitivity and specificity of 81% and 73%, respectively (AUC: 0.84, 95% CI: 0.74-0.92, p < .001). Logistic regression analysis showed that high SII (OR = 1.001, 95% CI = 1-1.001, p = .009) was identified as an independent predictor of major amputation in LEAD patients.ConclusionThis study establishes that a high SII value is associated with major amputation in LEAD patients with foot wounds.ResultSII is a valuable and straightforward parameter for predicting major amputation risk and guiding treatment decisions in LEAD patients.
More Related Videos
Related Concept Videos
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Inflammation III: Local and Systemic Effects
Chronic Inflammation: Introduction
Diabetic Foot Ulcer

